Cargando…
Cross species application of quantitative neuropathology assays developed for clinical Alzheimer’s disease samples
A major obstacle for preclinical testing of Alzheimer’s disease (AD) therapies is the availability of translationally relevant AD models. Critical for the validation of such models is the application of the same approaches and techniques used for the neuropathological characterization of AD. Deposit...
Autores principales: | Urfer, Silvan R., Latimer, Caitlin S., Ladiges, Warren, Keene, C. Dirk, Benbow, Sarah, Harrison, Benjamin, Promislow, Daniel E.L., Kaeberlein, Matt, Kraemer, Brian C, Wang, Adrienne, Guscetti, Franco, Darvas, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735310/ https://www.ncbi.nlm.nih.gov/pubmed/31528297 http://dx.doi.org/10.1080/20010001.2019.1657768 |
Ejemplares similares
-
Amyloid beta-42 Levels in Companion Dog Brains Correlate with Age and Cognitive Function
por: Urfer, Silvan, et al.
Publicado: (2020) -
Neuropathological assessment and validation of mouse models for Alzheimer's disease: applying NIA-AA guidelines
por: Keene, C. Dirk, et al.
Publicado: (2016) -
A geroscience mouse model for Alzheimer’s disease
por: Darvas, Martin, et al.
Publicado: (2019) -
Lifespan of companion dogs seen in three independent primary care veterinary clinics in the United States
por: Urfer, Silvan R., et al.
Publicado: (2020) -
Desexing Dogs: A Review of the Current Literature
por: Urfer, Silvan R., et al.
Publicado: (2019)